Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

bismuth subsalicylate

bismuth subsalicylate
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Pepto-Bismol, Bismatrol, Kaopectate, Kao-Tin SUSPENSION, ORAL 262 mg/15 mL      
Pepto-Bismol Maximum Strength SUSPENSION, ORAL 524 mg/15 mL    
Pepto-Bismol, Pink Bismuth TABLET, CHEWABLE, ORAL 262 mg      
VIEW MORE Antidiarrhea Agents
CLASS
560800
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

NOTES

bismuth subsalicylate (Pepto-Bismol Maximum Strength)*

  • 524 mg/15 mL suspension oral

bismuth subsalicylate (Pepto-Bismol)  

  • 262 mg/15 mL suspension oral

*Give 2 tablespoons (30 mL) for extra strength product substitutions

Please note: Pepto-Bismol contains salicylates. Avoid use in children less than 16 years of age.

Last updated: Dec. 14, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved